• Most Popular
  • Most Shared

Once-daily form of Glaxo's Requip filed with FDA

Fri Apr 13, 2007 2:01am EDT

Stocks

   

LONDON, April 13 (Reuters) - A once-daily form of GlaxoSmithKline Plc's (GSK.L) Parkinson's disease drug Requip has been filed for approved with the U.S. Food and Drug Administration.

Glaxo's partner on the project, SkyePharma Plc (SKP.L), whose technology was used to develop the extended-release formulation, said in a statement on Friday that the U.S. watchdog had accepted the filing of the application by Glaxo.

Requip is currently administered three times a day.

If approved for Parkinson's disease in the United States, SkyePharma will be entitled to a low mid-single digit percentage royalty on sales.

Requip is also sold for restless leg syndrome.

((Reporting by Ben Hirschler; email: ben.hirschler@reuters.com; Reuters Messaging: ben.hirschler.reuters.com@reuters.net; +44 20 7542 5082)) Keywords: SKYEPHARMA REQUIP/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWLB7641


More from Reuters

Photo

New security restrictions could hurt airlines

NEW YORK (Reuters) - Tighter security measures at U.S. airports following an attempt to blow up a Detroit-bound jet could dampen enthusiasm for air travel, hurting the airline industry just as it seemed poised to recover from a period of bruising losses, some industry experts say.

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets